1.
Kizlaitienė R, Giedraitienė N, Sereikė I, Liutkienė J, Leščinskienė L, Kaubrys G. Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic. NS [Internet]. 2020 Jun. 2 [cited 2024 Jul. 18];24(2(84):100-4. Available from: https://www.journals.vu.lt/neurologijos_seminarai/article/view/27741